Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01186276 · ClinicalTrials.gov registry record · NA

Dietary Maneuvers to Reduce Production of Colon-Derived Uremic Solutes

A NA study of Kidney Failure, Chronic, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
58
Enrollment target
3
Study locations

NCT01186276: Completed NA study of Kidney Failure, Chronic, sponsored by Stanford University.

NCT01186276 is a NA study of Kidney Failure, Chronic that has completed, run by Stanford University. The registered enrollment target is 58 participants, below the 330-participant average among 23 other Kidney Failure, Chronic trials with a reported enrollment target (82% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01186276, a NA study of Kidney Failure, Chronic, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
58 participants
Enrollment target
3
Study locations

Study Summary

This study will assess whether dietary fiber supplements can reduce the production of chemicals which are produced by colon bacteria and normally excreted from the body by the kidney, but build up in the body in patients on hemodialysis.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Fiber
  • DIETARY_SUPPLEMENT Corn starch

Study Locations (3)

California

  • VA Palo Alto Health Care System - Palo Alto
  • Satellite Dialysis - Redwood City
  • SCVMC - San Jose

Trial Details

FieldValue
Enrollment Target 58 participants
Start Date 2010-07
Est. Completion 2015-09
Phase NA
Stanford University

1,744 total trials

What the finished NCT01186276 record still lists

NCT01186276 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 330-participant average among 23 other Kidney Failure, Chronic trials with a reported enrollment target (82% lower).

The record links to 1 condition, with Kidney Failure, Chronic appearing as the primary indexed condition, and to 2 interventions - of which Fiber is the first listed.

NCT01186276 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01186276 about?

NCT01186276 is a clinical study titled "Dietary Maneuvers to Reduce Production of Colon-Derived Uremic Solutes". This study will assess whether dietary fiber supplements can reduce the production of chemicals which are produced by colon bacteria and normally excreted from the body by the kidney, but build up in the body in patients on hemodialysis.

What is the current status of trial NCT01186276?

This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2010-07. Estimated completion is 2015-09.

What conditions does trial NCT01186276 study?

This clinical trial studies the following conditions: Kidney Failure, Chronic.

What interventions are being tested in trial NCT01186276?

The interventions under investigation include: Fiber (DIETARY_SUPPLEMENT), Corn starch (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01186276?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01186276 being conducted?

This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Kidney Failure, Chronic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01186276's enrollment target sits among peer trials

58 11th of 23 higher than 11 of 23 other Kidney Failure, Chronic trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Kidney Failure, Chronic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03587844 · 58 participants · Phase 2

    Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients

  • NCT03630991 · 58 participants · Phase 1

    Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

  • NCT03949855 · 58 participants · Phase 2

    Belimumab With Rituximab for Primary Membranous Nephropathy

  • NCT04069273 · 58 participants · Phase 2

    Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01186276, the US trial registry maintained by the National Library of Medicine. NCT01186276 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.